Filing Details
- Accession Number:
- 0001209191-17-034764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-23 20:16:44
- Reporting Period:
- 2017-05-19
- Filing Date:
- 2017-05-23
- Accepted Time:
- 2017-05-23 20:16:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339358 | E Fred Cohen | Tpg Biotech 345 California Street Suite 3300 San Francisco CA 94104 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-19 | 8,250 | $14.37 | 74,145 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-19 | 8,250 | $29.54 | 65,895 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2017-05-19 | 8,250 | $0.00 | 0 | $14.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-06-11 | 2020-06-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,068 | Indirect | By the Jane K Cohen Trust |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $29.35 to $29.80.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
